Logo image of ALJJ

ALJ REGIONAL HOLDINGS INC (ALJJ) Stock Fundamental Analysis

USA - NASDAQ:ALJJ - US0016271084 - Common Stock

1.62 USD
-0.2 (-10.99%)
Last: 9/9/2022, 8:25:02 PM
1.6 USD
-0.02 (-1.23%)
After Hours: 9/9/2022, 8:25:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALJJ. ALJJ was compared to 86 industry peers in the IT Services industry. ALJJ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALJJ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALJJ had positive earnings in the past year.
ALJJ Yearly Net Income VS EBIT VS OCF VS FCFALJJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M -40M -60M

1.2 Ratios

Industry RankSector Rank
ROA 65.31%
ROE 92.48%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALJJ Yearly ROA, ROE, ROICALJJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -100 -200 -300

1.3 Margins

Industry RankSector Rank
OM -3.8%
PM (TTM) 45.62%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALJJ Yearly Profit, Operating, Gross MarginsALJJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20

More info and screens

4

2. Health

2.1 Basic Checks

ALJJ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALJJ has more shares outstanding
Compared to 1 year ago, ALJJ has an improved debt to assets ratio.
ALJJ Yearly Shares OutstandingALJJ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M
ALJJ Yearly Total Debt VS Total AssetsALJJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

2.2 Solvency

ALJJ has an Altman-Z score of 3.41. This indicates that ALJJ is financially healthy and has little risk of bankruptcy at the moment.
ALJJ has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 3.41
ROIC/WACCN/A
WACC11.79%
ALJJ Yearly LT Debt VS Equity VS FCFALJJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

2.3 Liquidity

ALJJ has a Current Ratio of 4.78. This indicates that ALJJ is financially healthy and has no problem in meeting its short term obligations.
ALJJ has a Quick Ratio of 4.78. This indicates that ALJJ is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 4.78
ALJJ Yearly Current Assets VS Current LiabilitesALJJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2436.85% over the past year.
ALJJ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.96%.
Measured over the past years, ALJJ shows a quite strong growth in Revenue. The Revenue has been growing by 10.43% on average per year.
EPS 1Y (TTM)2436.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3489.3%
Revenue 1Y (TTM)-22.96%
Revenue growth 3Y6.03%
Revenue growth 5Y10.43%
Sales Q2Q%-20.8%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALJJ Yearly Revenue VS EstimatesALJJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.64, the valuation of ALJJ can be described as very cheap.
ALJJ's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.57.
Industry RankSector Rank
PE 0.64
Fwd PE N/A
ALJJ Price Earnings VS Forward Price EarningsALJJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -17.22
ALJJ Per share dataALJJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALJJ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALJ REGIONAL HOLDINGS INC

NASDAQ:ALJJ (9/9/2022, 8:25:02 PM)

After market: 1.6 -0.02 (-1.23%)

1.62

-0.2 (-10.99%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-10 2022-08-10
Earnings (Next)12-19 2022-12-19
Inst Owners0.71%
Inst Owner Change0%
Ins Owners34.77%
Ins Owner Change0%
Market Cap62.63M
Revenue(TTM)312.58M
Net Income(TTM)142.59M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.64
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.41
P/tB N/A
EV/EBITDA -17.22
EPS(TTM)2.54
EY156.79%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.09
BVpS3.99
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 65.31%
ROE 92.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -3.8%
PM (TTM) 45.62%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.78
Quick Ratio 4.78
Altman-Z 3.41
F-Score4
WACC11.79%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2436.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3489.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.96%
Revenue growth 3Y6.03%
Revenue growth 5Y10.43%
Sales Q2Q%-20.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A